Brief: ​​​​​​​Paion Says NMPA Accepts Submission Of New Drug Application For Remimazolam Besylate

PAION AG

09/07/2021 10:31

July 9 (Reuters) - PAION AG  PA8G.DE :
    * ​​​​​​​PAION ANNOUNCES THAT NMPA ACCEPTS SUBMISSION OF NEW
DRUG
APPLICATION FOR REMIMAZOLAM BESYLATE IN GENERAL ANESTHESIA BY
CHINESE LICENSEE YICHANG HUMANWELL

Source text for Eikon:  ID:nEQ8GCwDKa 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))